Form D · Biotechnology
CytoBioscience, Inc.
San Antonio, TX · CIK 0001637514
Offering snapshot reported Mar 16, 2018 · SEC filing
- Reported sold
- $1.53M Offering amount: $1.53M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 1, 2018 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 16, 2018 | Amendment | $1,530,000 | $0vs Mar 15, 2018 | 3 | SEC filing |
| Mar 15, 2018 | Initial | $1,530,000 | No comparison | 3 | SEC filing |
| Jan 23, 2018 | Amendment | $15,821,845 | $0vs Jan 22, 2018 | 11 | SEC filing |
| Jan 22, 2018 | Amendment | $15,821,845 | $0vs Aug 10, 2016 | 11 | SEC filing |
| Aug 10, 2016 | Amendment | $15,821,845 | $9,184,500vs Mar 26, 2015 | 11 | SEC filing |
| Mar 26, 2015 | Initial | $0 | No comparison | 2 | SEC filing |
| Mar 26, 2015 | Initial | $6,637,345 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $90K
- Finders' fees
- $0
- Form D file number
- 021-307871
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Danielle Hughes | 2189447 | Divine Capital Markets · CRD 118212 |
Source: Form D, filed Mar 16, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Castella | Director |
| Ian Clements | Director |
| Alan Dean | Director |
| James R. Garvin | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:San Antonio, TX, 78229